Patient involvement in clinical research: Why, when, and how

Patient Preference and Adherence

Volumn 10, Issue , 2016, Pages 631-640

  Sacristán, José A ^a   Aguarón, Alfonso ^b   Avendaño Solá, Cristina ^c   Garrido, Pilar ^d   Carrión, Juan ^e   Gutiérrez, Alipio ^f   Kroes, Robert ^g   Flores, Angeles ^a  

^a Medical Department   (Spain)

^b Myeloma Patients Europe   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e FEDER (Spanish Federation for Rare Diseases)   (Spain)

^f Lilly Europe ^*  (Spain)

^g Clinical Open Innovation   (Netherlands)

Author keywords

Bioethics; Clinical trials; Engagement; Patients; Research

Indexed keywords

BENEFICENCE; BIOETHICS; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; HUMAN; LEADERSHIP; MODEL; PATIENT PARTICIPATION;

EID: 84969900619     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S104259     Document Type: Review

References (90)

1. Laine C, Davidoff F. Patient-centered medicine. A professional evolution. JAMA. 1996;275:152-156.
2. Lipkin M. Shared decision making. JAMA Intern Med. 2013;173:1204-1205.
3. Porter ME. What is value in health care? N Engl J Med. 2010;363:2477-2481.
4. Tinetti ME, Basch E. Patients’ responsibility to participate in decision making and research. JAMA. 2013;309:2331-2332.
5. Lloyd K, White J. Democratizing clinical research. Nature. 2011;474:277-278.
6. Thornton S. Beyond rhetoric: we need a strategy for patient involvement in the health service. BMJ. 2014;348:g4072.
7. Domecq JP, Prutsky G, Elraiyah T, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14:89.
8. Caron-Flinterman JF, Broerse JE, Bunders JF. The experiential knowledge of patients: a new resource for biomedical research? Soc Sci Med. 2005;60:2575-2584.
9. Hanley B, Truesdale A, King A, Elbourne D, Chalmers I. Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. BMJ. 2001;322:519-523.
10. van der Scheer L, Garcia E, van der Laan AL, van der Burg S, Boenink M. The benefits of patient involvement for translational research. Health Care Anal. Epub 2014 Dec 24.
11. Jenks S. The public applauds cancer research but not how research priorities are set. J Natl Cancer Inst. 1997;89:350-351.
12. Elwyn G, Crowe S, Fenton M, et al. Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions. J Eval Clin Pract. 2010;16:627-631.
13. Fleurence RL, Forsythe LP, Lauer M, et al. Engaging patients and stakeholders in research proposal review: the patient-centered outcomes research institute. Ann Intern Med. 2014;161:122-130.
14. Chalmers I, Atkinson P, Fenton M, Firkins L, Crowe S, Cowan K. Tackling treatment uncertainties together: the evolution of the James Lind Initiative, 2003-2013. J R Soc Med. 2013;106:482-491.
15. Petit-Zeman S, Firkins L, Scadding JW. The James Lind Alliance: tackling research mismatches. Lancet. 2010;376:667-669.
16. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86-89.
17. Vayena E. The next step in the patient revolution: patients initiating and leading research. BMJ. 2014;349:g4318.
18. Kaye J, Curren L, Anderson N, et al. From patients to partners: participant-centric initiatives in biomedical research. Nat Rev Genet. 2012;13:371-376.
19. Swan M. Crowdsourced health research studies: an important emerging complement to clinical trials in the public health research ecosystem. J Med Internet Res. 2012;14(2):e46.
20. Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009;151:203-205.
21. Barr PJ, Elwyn G. Measurement challenges in shared decision making: putting the ‘patient’ in patient-reported measures. Health Expect. Epub 2015 Jun 25.
22. Mullins CD, Vandigo J, Zheng Z, Wicks P. Patient-centeredness in the design of clinical trials. Value Health. 2014;17:471-475.
23. Murad MH, Shah ND, Van Houten HK, et al. Individuals with diabetes preferred that future trials use patient-important outcomes and provide pragmatic inferences. J Clin Epidemiol. 2011;64:743-748.
24. Basch E. Toward patient-centered drug development in oncology. N Engl J Med. 2013;369:397-400.
25. Lindenmeyer A, Hearnshaw H, Sturt J, Ormerod R, Aitchison G. Assessment of the benefits of user involvement in health research from the Warwick Diabetes Care Research User Group: a qualitative case study. Health Expect. 2007;10:268-277.
26. Ali K, Roffe C, Crome P. What patients want: consumer involvement in the design of a randomized controlled trial of routine oxygen supplementation after acute stroke. Stroke. 2006;37:865-871.
27. de Wit M, Abma T, Koelewijn-van Loon M, Collins S, Kirwan J. Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open. 2013;3(5):e002241.
28. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Silver Spring, MD: U.S. Department of Health and Human Services Food and Drug Administration; 2009.
29. Dinan MA, Compton KL, Dhillon JK, et al. Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials. Med Care. 2011;49:415-419.
30. Gandhi GY, Murad MH, Fujiyoshi A, et al. Patient-important outcomes in registered diabetes trials. JAMA. 2008;299:2543-2549.
31. Rahimi K, Malhotra A, Banning AP, Jenkinson C. Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review. BMJ. 2010;341:c5707.
32. Gnanasakthy A, Mordin M, Clark M, DeMuro C, Fehnel S, Copley-Merriman C. A review of patient-reported outcome labels in the United States: 2006 to 2010. Value Health. 2012;15:437-442.
33. Willke RJ, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials. 2004;25:535-552.
34. Coons SJ, Kothari S, Monz BU, Burke LB. The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims. Clin Pharmacol Ther. 2011;90:743-748.
35. Garratt A. Patient reported outcome measures in trials. BMJ. 2009;338:a2597.
36. Vieta A, Badia X, Sacristan JA. A systematic review of patient-reported and economic outcomes: value to stakeholders in the decision-making process in patients with type 2 diabetes mellitus. Clin Ther. 2011;33:1225-1245.
37. Vieta A, Badia X, Álvarez E, Sacristán JA. Which nontraditional outcomes should be measured in healthcare decision-making in schizophrenia? A systematic review. Perspect Psychiatr Care. 2012;48:198-207.
38. Wolpert M, Ford T, Trustam E, et al. Patient-reported outcomes in child and adolescent mental health services (CAMHS): use of idiographic and standardized measures. J Ment Health. 2012;21:165-173.
39. McCartney M. How do we know whether medical apps work? BMJ. 2013;346:f1811.
40. Kamerow D. Regulating medical apps: which ones and how much? BMJ. 2013;347:f6009.
41. Harris J. Scientific research is a moral duty. J Med Ethics. 2005;31:242-248.
42. The Patient Access to Cancer Care Excellence (PACE) [homepage on the Internet]. Available from: https://pacenetwork.com/. Accessed September 28, 2015.
43. Gifford AL, Cunningham WE, Heslin KC, et al; HIV Cost and Services Utilization Study Consortium. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002;346:1373-1382.
44. Unger JM, Hershman DL, Albain KS, et al. Patient income level and cancer clinical trial participation. J Clin Oncol. 2013;31:536-542.
45. Gelijns AC, Gabriel SE. Looking beyond translation-integrating clinical research with medical practice. N Engl J Med. 2012;366:1659-1661.
46. Sacristan JA. Clinical research and medical care: towards effective and complete integration. BMC Med Res Methodol. 2015;15:4.
47. Sacristán JA, Soto J, Galende I, Hylan TR. Randomized database studies: a new method to assess drugs’ effectiveness? J Clin Epidemiol. 1998;51:713-715.
48. Lauer MS, D’Agostino RB Sr. The randomized registry trial-the next disruptive technology in clinical research? N Engl J Med. 2013;369:1579-1581.
49. Sacristan JA, Dilla T. No big data without small data: learning health care systems begin and end with the individual patient. J Eval Clin Pract. 2015;21(6):1014-1017.
50. Paasche-Orlow MK, Taylor HA, Brancati FL. Readability standards for informed-consent forms as compared with actual readability. N Engl J Med. 2003;348:721-726.
51. Taylor HE, Bramley DE. An analysis of the readability of patient information and consent forms used in research studies in anaesthesia in Australia and New Zealand. Anaesth Intensive Care. 2012;40:995-998.
52. Hereu P, Pérez E, Fuentes I, Vidal X, Suñé P, Arnau JM. Consent in clinical trials: what do patients know? Contemp Clin Trials. 2010;31:443-446.
53. Tam NT, Huy NT, Thoa le TB, et al. Participants’ understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis. Bull World Health Organ. 2015;93:186H-198H.
54. Dreyfuss D. Is it better to consent to an RCT or to care? Muetadeltaepsilonnu alphagammaalphanu (“nothing in excess”). Intensive Care Med. 2005;31:345-355.
55. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC.
56. Henderson GE, Churchill LR, Davis AM, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007;4:e324.
57. Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ. Patients’ decision-making process regarding participation in phase I oncology research. J Clin Oncol. 2006;24:4479-4484.
58. Vist GE, Bryant D, Somerville L, Birminghem T, Oxman AD. Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev. 2008;(3):MR000009.
59. Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial. BMJ. 2002;325:415.
60. Villen N, Redondo S, Font R, Quintana S. Perfil de los miembros no sanitarios de los comités éticos de investigación clínica y comités de ética asistencial de Cataluña [Profile of lay members of ethics committees in Catalonia (Spain)]. Med Clin. 2012;138:296-299. Spanish.
61. Pletcher MJ, Lo B, Grady D. Informed consent in randomized quality improvement trials: a critical barrier for learning health systems. JAMA Intern Med. 2014;174:668-670.
62. Brehaut JC, Fergusson DA, Kimmelman J, Shojania KG, Saginur R, Elwyn G. Using decision aids may improve informed consent for research. Contemp Clin Trials. 2010;31:218-220.
63. Gillies K, Skea ZC, Campbell MK. Decision aids for randomised controlled trials: a qualitative exploration of stakeholders’ views. BMJ Open. 2014;4:e005734.
64. Tallon D, Mulligan J, Wiles N, et al. Involving patients with depression in research: survey of patients’ attitudes to participation. Br J Gen Pract. 2011;61:134-141.
65. Kost RG, Lee LM, Yessis J, Coller BS, Henderson DK; Research Participant Perception Survey Focus Group Subcommittee. Assessing research participants’ perceptions of their clinical research experiences. Clin Trans Sci. 2011;4:403-413.
66. Kost RG, Lee LM, Yessis J, Wesley RA, Henderson DK, Coller BS. Assessing participant-centered outcomes to improve clinical research. N Engl J Med. 2013;369:2179-2181.
67. Wendler D, Krohmal B, Emanuel EJ, Grady C; ESPRIT Group. Why patients continue to participate in clinical research. Arch Intern Med. 2008;168:1294-1299.
68. Holmberg C, Karner JJ, Rappenecker J, Witt CM. Clinical trial participants’ experiences of completing questionnaires: a qualitative study. BMJ Open. 2014;4:e004363.
69. Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP. Do patients participating in clinical trials want to know study results? J Natl Cancer Inst. 2003;95:491-492.
70. MacNeil SD, Fernandez CV. Attitudes of research ethics board chairs towards disclosure of research results to participants: results of a national survey. J Med Ethics. 2007;33:549-553.
71. Partridge AH, Winer EP. Informing clinical trial participants about study results. JAMA. 2002;288:363-365.
72. Dal-Re R, Costa J. Información de los resultados a los participantes de los ensayos clínicos [Informing clinical trials participants about the results]. Med Clin. 2007;128:375-378. Spanish.
73. Shalowitz DI, Miller FG. Disclosing individual results of clinical research: implications of respect for participants. JAMA. 2005;294:737-740.
74. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191-2194.
75. Dalal H, Wingham J, Pritchard C, et al. Communicating the results of research: how do participants of a cardiac rehabilitation RCT prefer to be informed? Health Expect. 2010;13:323-330.
76. Avins AL, Bent S, Padula A, Staccone S, Badua E, Goldberg H. Initial experience with a group presentation of study results to research participants. Trials. 2008;9:16.
77. Dorsey ER, Beck CA, Adams M, et al; Huntington Study Group TREND-HD Investigators. Communicating clinical trial results to research participants. Arch Neurol. 2008;65:1590-1595.
78. Richards T, Montori VM, Godlee F, Lapsley P, Paul D. Let the patient revolution begin. BMJ. 2013;346:f2614.
79. Balas EA, Boren SA. Yearbook of Medical Informatics: Managing Clinical Knowledge for Health Care Improvement. Germany: Schattauer Verlagsgesellscaft mbH; 2000;65-70.
80. Coulter A, Locock L, Ziebland S, Calabrese J. Collecting data on patient experience is not enough: they must be used to improve care. BMJ. 2014;348:g2225.
81. Thompson IM Jr, Leach RJ, Ankerst DP. Focusing PSA testing on detection of high-risk prostate cancers by incorporating patient preferences into decision making. JAMA. 2014;312:995-996.
82. Rosenblatt M, Jain SH, Cahill M. Sharing of clinical trial data: benefits, risks, and uniform principles. Ann Intern Med. 2015;162:306-307.
83. Ross JS, Krumholz HM. Ushering in a new era of open science through data sharing: the wall must come down. JAMA. 2013;309:1355-1356.
84. Goodman SN. Clinical trial data sharing: what do we do now? Ann Intern Med. 2015;162:308-309.
85. Lo B. Sharing clinical trial data: maximizing benefits, minimizing risk. JAMA. 2015;313:793-794.
86. Bonini S, Eichler HG, Wathion N, Rasi G. Transparency and the European Medicines Agency-sharing of clinical trial data. N Engl J Med. 2014;371:2452-2455.
87. Elberse JE, Caron-Flinterman JF, Broerse JE. Patient-expert partnerships in research: how to stimulate inclusion of patient perspectives. Health Expect. 2011;14:225-239.
88. Cordier JF. The expert patient: towards a novel definition. Eur Respir J. 2014;44:853-857.
89. Chakradhar S. Training on trials: patients taught the language of drug development. Nat Med. 2015;21:209-210.
90. Elberse JE, Pittens CA, de Cock Buning T, Broerse JE. Patient involvement in a scientific advisory process: setting the research agenda for medical products. Health Policy. 2012;107:231-242.